Surface Oncology Inc

NASDAQ:SURF   3:59:38 PM EDT
9.03
+1.17 (+14.88%)
Products

Surface Oncology Announces FDA Fast Track Designation Granted By U.S. Food And Drug Administration For SRF388 To Treat Liver Cancer

Published: 11/11/2020 12:30 GMT
Surface Oncology Inc (SURF) - Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for Srf388 to Treat Liver Cancer.